Clinical Trial Update: Infrared Coagulator Ablation or Observation in Preventing Anal Cancer in HIV-Positive Patients With Anal Neoplasia [Phase 3]

View source ↗

Summary

A phase 3 trial evaluating infrared coagulator ablation versus observation to prevent anal cancer in HIV-positive individuals with anal neoplasia has completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anal Cancer

Snippet

Sponsor: AIDS Malignancy Consortium | Conditions: Anal Cancer, Neoplasm of Uncertain Malignant Potential | Phase 3 | Status: COMPLETED | Results posted: 2016-10-31